Please assess the completion status of the following clinical trial:

Trial Title: Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing bone marrow aspiration (unilateral), with lumbar puncture and intrathecal chemotherapy.~* Age 2 to 17 years~* ASA I-III~* Patients with acute lymphoblastic leukemia or lymphoblastic lymphoma in remission or on the day of anticipated remission procedures occurring at the end of remission induction.~* Patients must have three anticipated bone marrow aspirates and lumbar punctures with intrathecal chemotherapy remaining in their treatment~Exclusion Criteria:~* Newly diagnosed patients~* Patients with low platelet count (less than 50000)~* Patients undergoing bone marrow biopsy in addition to bone marrow aspiration~* Age less than 2 years or over 17 years~* ASA IV-V~* Patients taking opioid medication for pre-existent pain for more than 2 weeks at the time of the procedure~* Neurological impairment that would increase susceptibility to opioids (Down's syndrome)~* Clinical contraindications for general anesthesia (large mediastinal mass) or specific use of propofol, Fentanyl, EMLA, L•M•X 4™ or Lidocaine for injection

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Fentanyl-1mcg/kg in 3 ml of Normal Saline
- 2 (Type: ACTIVE_COMPARATOR): Fentanyl - 0.5 mcg/kg in 3 ml normal saline
- 3 (Type: PLACEBO_COMPARATOR): normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).